Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans

Phillip R. Pittman, David McClain, Xiaofei Quinn, Kevin M. Coonan, Joseph Mangiafico, Richard S. Makuch, John Morrill, Clarence J. Peters

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Social Sciences